BD To Achieve Safety Products Sales Target Early Aided By OSHA Revision
This article was originally published in The Gray Sheet
Executive Summary
The Needlestick Safety and Prevention Act and subsequent revision to the Occupational Safety and Health Administration's bloodborne pathogens standard will help BD Corp. reach the $800 mil. sales mark by the end of 2003, the firm is now projecting, well ahead of its earlier forecast of 2005.